Drug factory · FDA FEI 3004065859
Sci Pharmtech, Inc.
No.61, Ln. 309, Haihu N. Rd., Luzhu Dist., Taoyuan City, Taiwan
Problems found, fixed voluntarily at FDA's last inspection, Jun 6, 2025.
Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.
5 drug inspections on record since 2012: 2 with no problems, 3 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Duloxetine | Makes the active ingredient | Qingdao BAHEAL Pharmaceutical Co., Ltd. | 70247-012, 70247-013, 70247-014 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Jun 6, 2025 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Sep 5, 2019 | No problems found | Drug Quality Assurance | — |
| Sep 15, 2017 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Dec 19, 2014 | No problems found | Drug Quality Assurance | — |
| Apr 20, 2012 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
Registered with FDA for: analysis; api manufacture.